Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-02

Clinical Trial Update: Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement [Phase 2]

View source ↗

Summary

Phase 2 trial update on DU-176b for preventing blood clots in hip replacement patients; study completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DU-176b

Snippet

Sponsor: Daiichi Sankyo | Conditions: Arthroplasty, Replacement, Hip, Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2015-03-02